Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome
Kwi-Hyun Bae (Bae KH), Sung Woo Kim (Kim SW), Yeon-Kyung Choi (Choi YK), Jung Beom Seo (Seo JB), Namkyun Kim (Kim N), Chang-Yeon Kim (Kim CY), Won Kee Lee (Lee WK), Sungwoo Lee (Lee S), Jung Guk Kim (Kim JG), In-Kyu Lee (Lee IK), Jang Hoon Lee (Lee JH), Keun-Gyu Park (Park KG)
Diabetes Metab J. 2018;42(3):207-214.   Published online 2018 May 2     DOI: https://doi.org/10.4093/dmj.2017.0081
Citations to this article as recorded by Crossref logo
Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall
Yanan Guo, Binjie Yan, Yu Gui, Zhihan Tang, Shi Tai, Shenghua Zhou, Xi‐Long Zheng
Journal of Cellular Physiology.2021; 236(4): 2333.     CrossRef
PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction
Marianne Zeller, Gilles Lambert, Michel Farnier, Maud Maza, Brice Nativel, Luc Rochette, Catherine Vergely, Yves Cottin
Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(3): 880.     CrossRef
Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction
Jing Gao, Ya-Nan Yang, Zhuang Cui, Si-Yuan Feng, Jing Ma, Chang-Ping Li, Yin Liu
Lipids in Health and Disease.2021;[Epub]     CrossRef
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
Yuen-Kwun Wong, Hung-Fat Tse
Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
PCSK9 in acute coronary syndrome: analysis of associations with clinical and laboratory characteristics
Yu. A. Drenina, K. Yu. Nikolaev
Cardiovascular Therapy and Prevention.2020; 19(4): 2484.     CrossRef
Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
Ik Jun Choi, Sungmin Lim, Dongjae Lee, Won Jik Lee, Kwan Yong Lee, Mi-Jeong Kim, Doo Soo Jeon
The American Journal of Cardiology.2020; 133: 54.     CrossRef
A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America
Ashraf Reda, Wael Almahmeed, Idit Dobrecky-Mery, Po-Hsun Huang, Ursulo Juarez-Herrera, Naresh Ranjith, Tobias Sayre, Miguel Urina-Triana
Advances in Therapy.2020; 37(5): 1754.     CrossRef
PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
Štefan Tóth, Peter Olexa, Zdenka Hertelyová, Peter Štefanič, Ivan Kopolovets, Peter Berek, Vladimir Filip, Ryan Chakravarty, Monika Široká, Daniel Pella
Open Chemistry.2020; 18(1): 1011.     CrossRef
Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus
Wen Guo, Yingyun Gong, Jie Li, Pei Qin, Jing Lu, Xiaona Li, Wenfang Zhu, Nianzhen Xu, Hongwen Zhou, Qun Zhang
Nutrition, Metabolism and Cardiovascular Diseases.2019; 29(8): 815.     CrossRef
PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography
Yunes Panahi, Mohsen Sadeghi Ghahrodi, Mohsen Jamshir, Mohammad Amin Safarpour, Vanessa Bianconi, Matteo Pirro, Maryam Moshkani Farahani, Amirhossein Sahebkar
Clinical Biochemistry.2019; 74: 12.     CrossRef
Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
Chiara Caselli, Serena Del Turco, Rosetta Ragusa, Valentina Lorenzoni, Michiel De Graaf, Giuseppina Basta, Arthur Scholte, Raffaele De Caterina, Danilo Neglia
Cardiovascular Diabetology.2019;[Epub]     CrossRef
PCSK9 inhibition and inflammation: A narrative review
Massimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini, Cesare R. Sirtori
Atherosclerosis.2019; 288: 146.     CrossRef
Letter: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
Jin Hwa Kim
Diabetes & Metabolism Journal.2018; 42(4): 348.     CrossRef
Response: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
Sung Woo Kim, Keun-Gyu Park
Diabetes & Metabolism Journal.2018; 42(4): 350.     CrossRef
Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population
Gaojun Cai, Lei Yu, Zhiying Huang, Li Li, Xingli Fu
Lipids in Health and Disease.2018;[Epub]     CrossRef